The adverse effects of mydriatic agents are well documented. These include severe hypertension, subarachnoid haemorrhage, ventricular arrhyth mias, and myocardial infarction.1 Subconjunctival injections of mydriatic agents are recommended by some authorities to dilate pupils in uveitic patients with posterior synechiae? These agents are also used to achieve and maintain mydriasis perioperatively during prolonged vitreoretinal procedures. These injections can lead to significant systemic absorption and serious complications? the risk being enhanced by conjunctival hyperaemia.
Following induction of anaesthesia patients under going complicated vitreoretinal procedures at New castle General Hospital routinely receive a sUbconjunctival injection of a mixture comprising 1 mg atropine, 0.12 mg adrenaline and 6 mg procaine (Mydricaine No. 2, formulated by Moorfields Eye Hospital). We report three instances in previously healthy individuals of prolonged supraventricular tachycardia induced by the subconjunctival injection of these mydriatic agents.
Case Reports All three patients had surgery under general anaesthesia, which was performed by the same senior anaesthetist. The induction agents used for anaesthesia were identical, i.e. fentanyl and propofol. Anaesthesia was maintained in each patient by a mixture of 70% nitrous oxide, 29% oxygen and 1 % isofiurane. Ventilation was maintained with inter mittent positive pressure via a laryngeal mask. No anticholinergic drugs were used by the anaesthetist.
Each patient was previously healthy, with no history of cardiovascular disease, and was under going complex retinal surgery. Two of the patients had suffered recent ocular trauma. Patient 1 was
Heart rate 100 Within 5 minutes of injection of Mydricaine subconjunctivally, the pulse rate of each patient rose dramatically (Fig. 1) . In addition, in two of the patients a rise in blood pressure was noted also within 5 minutes. In patient 1 it rose from 150/70 to 195/95 mmHg; this steadily decreased over 30 minutes. In patient 2 the blood pressure rose from 100/50 to 145/75 mmHg; this steadily decreased over 15 minutes. All other parameters monitored remained unchanged. All patients made uneventful recoveries.
Discussion
Disturbances of the cardiac rhythm during ophthal mic surgery are observed in all patients of all ages.4 Extrasystoles and sustained cardiac arrhythmias are particularly common in older patients. 4 Atropine when given intravenously appears to have a protective effect on the oculo-cardiac reflex. 4 Atropine is an anticholinergic drug. Systemic absorption of subconjunctival atropine can result in adverse side-effects. 3 ,5 Cardiac dysrhythmias are one of the major adverse reactions. Atrial fibrillation and supraventricular tachycardia can be precipitated by the drug.5 Cardiac effects of atropine should be considered carefully before administration of the drug via the subconjunctival route in patients with cardiac dysrhythmias.
Adrenaline is a potent, direct-acting alpha 1 agonist. Stimulation of these receptors can cause constriction of the systemic, pulmonary and coronary arteries, leading to severe hypertension, arrhythmias and myocardial infarction? Procaine produces a tachycardia but its effect is significantly less than that produced by cocaine. 6 It is conceivable that in our patients atropine, adrenaline and procaine caused the prolonged tachycardia by an additive effect and that in two of the patients their systemic absorption was enhanced by conjunctival hyperaemia secondary to the recent trauma.
Potent mydriatic agents such as Mydricaine are used to dilate pupils in hyperaemic uveitic eyes with posterior synechiae at outpatient clinics. We advise extreme caution when using these agents via the subconjunctival route in patients with previous cardiovascular disease and, in particular, a history of dysrhythmias. Careful patient selection should minimise severe cardiac complications. 
